Lucentis and Rotator cuff syndrome - a phase IV clinical study of FDA data

Summary:

Rotator cuff syndrome is reported as a side effect among people who take Lucentis (ranibizumab), especially for people who are male, 60+ old, also take Avastin, and have Muscle spasms.

The phase IV clinical study analyzes which people have Rotator cuff syndrome when taking Lucentis. It is created by eHealthMe based on reports of 25,577 people who have side effects when taking Lucentis from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Rotator cuff syndrome?

Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder) is found to be associated with 1,087 drugs and 1,122 conditions by eHealthMe. Check the latest studies of Rotator cuff syndrome.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

25,577 people reported to have side effects when taking Lucentis.
Among them, 15 people (0.06%) have Rotator cuff syndrome.

Could Lucentis cause Rotator cuff syndrome?

Among these 15 people:

What is the gender of people who have Rotator cuff syndrome when taking Lucentis? *

female: 40 %
male: 60 %

What is the age of people who have Rotator cuff syndrome when taking Lucentis? *

What are other drugs people take besides Lucentis? *

What are other side effects people have besides Rotator cuff syndrome? *

Pain: 9 people, 60.00%
Visual Impairment: 9 people, 60.00%
Cataract (clouding of the lens inside the eye): 9 people, 60.00%
Balance Disorder: 9 people, 60.00%
Gingivitis (inflammation of gums): 8 people, 53.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 8 people, 53.33%
Dysaesthesia (abnormal sensation): 8 people, 53.33%
Dyspnea (difficult or laboured breathing): 8 people, 53.33%
Ejection Fraction Decreased (systolic heart failure): 8 people, 53.33%
Enlarged Heart: 8 people, 53.33%

What are the existing conditions these people have? *

Muscle Spasms (muscle contraction): 9 people, 60.00%
Toothaches (tooth pain): 8 people, 53.33%
Depression: 4 people, 26.67%
Bone Neoplasm Malignant (cancer of bone): 3 people, 20.00%
Constipation: 2 people, 13.33%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 2 people, 13.33%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 6.67%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 6.67%
Neuropathy Peripheral (surface nerve damage): 1 person, 6.67%
Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and have Rotator cuff syndrome?

- Check whether Rotator cuff syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lucentis:

Lucentis (25,647 reports)

Browse all side effects of Lucentis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rotator cuff syndrome:

Rotator cuff syndrome (1,087 drugs)

Browse all the conditions that are associated with Rotator cuff syndrome:

Rotator cuff syndrome (1,122 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranibizumab (the active ingredients of Lucentis) and Lucentis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.